MG1655 is an Escherichia coli K-12 strain that does not express O-antigen, a distal sugar component of lipopolysaccharide (LPS) on Gram-negative bacteria. DFB1655 L9 is an isogenic strain of MG1655 with O16-antigen expression restored. Studies have shown that DFB1655 L9 is resistant to T4 bacteriophage infection, whereas MG1655 is susceptible. How O16-antigen confers resistance to T4 is unknown. Elucidating this resistance mechanism will provide insight into the functional role of O-antigen. Here, we investigated the effects of soluble O16-antigen on T4 adsorption to E. coli K-12 by performing a time series adsorption assay of T4 to MG1655 using T4 pre-treated with LPS with or without O16-antigen. The free phage concentration in the supernatant, representing the unadsorbed phage, was quantified via double agar overlay plaque assays. We observed a similar trend between the control group and the treatment group of T4 incubated with LPS without O16-antigen, in which free phage concentration decreased rapidly to 3.10% and 2.99% at t = 5 minutes, respectively. When T4 was incubated with LPS with O16-antigen, a delayed decrease of free phage concentration was observed, with 17% of the initial free phage concentration remaining at t = 5 minutes. However, eventually phage in the supernatant of all groups depleted. Therefore, we conclude that soluble O16-antigen LPS complex was able to delay T4 adsorption to MG1655 but did not confer long-term resistance. This provides evidence that soluble O16-antigen likely affects T4 bacteriophage infectivity through reversible interactions and delays its rate of adsorption to the cell surface.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: